Simvastatin with fenofibrate - Lipid modification
You are here : Home > Formulary Search > Simvastatin with fenofibrate - Lipid modification
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
See narrative
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Simvastatin with fenofibrate
Indication :
Lipid modification
Group Name :
Keywords :
statins, fibrates, mixed dyslipidaemia, triglycerides, cholesterol lowering, high cholesterol, hyperlipidaemia, lipid-lowering, lipid lowering
Brand Names Include :
Cholib
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Simvastatin with fenofibrate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Lipid modification.
Committee Recommendations (1)
23 May 16 -
Not Set
This drug has not yet been evaluated by NICE or the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.
This drug is currently not on the PCN work-plan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.
This drug is currently not on the PCN work-plan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.